Peptide record

TPDB19035

Antibacterial Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB19035
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 17-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
FFSLIPKLVGKLISAFK
Physicochemical Analysis
C96H154N20O20
RNDCEQHMTWY
LKF
1908.40
10.84
3
0
10
+3
-2.10
1.147
137.65
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
3
L
3
K
0
M
3
F
1
P
2
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 3 K: 3 M: 0 F: 3 P: 1 S: 2 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
17
C96H154N20O20
1908.40
10.84
+3
-2.10
1.147
Evidence Records 2 records
Evidence 1 Activity

Activity

11.5% Hemolysis
Toxicity
9.17 µM
Hemolytic Cytotoxic
11.5% Hemolysis | 9.17 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
In silico and in vitro structure-stability-function relationship of analog peptides of Stigmurin and its antibacterial and antibiofilm activities. | Pharmacol Res | 2022
Evidence 2 Activity

Activity

15% Hemolysis
Toxicity
150 µM
Hemolytic Cytotoxic
15% Hemolysis | 150 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
In silico and in vitro structure-stability-function relationship of analog peptides of Stigmurin and its antibacterial and antibiofilm activities. | Pharmacol Res | 2022